• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

趋化因子受体CX3CR1与丙型肝炎病毒慢性感染所致的肝纤维化有关。

The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection.

作者信息

Wasmuth Hermann E, Zaldivar Mirko Moreno, Berres Marie-Luise, Werth Alexa, Scholten David, Hillebrandt Sonja, Tacke Frank, Schmitz Petra, Dahl Edgar, Wiederholt Tonio, Hellerbrand Claus, Berg Thomas, Weiskirchen Ralf, Trautwein Christian, Lammert Frank

机构信息

Medical Department III, University Hospital Aachen, Pauwelsstrasse 30, D-52057 Aachen, Germany.

出版信息

J Hepatol. 2008 Feb;48(2):208-15. doi: 10.1016/j.jhep.2007.09.008. Epub 2007 Nov 20.

DOI:10.1016/j.jhep.2007.09.008
PMID:18078680
Abstract

BACKGROUND/AIMS: The chemokine receptor CX3CR1 and its specific ligand fractalkine (CX3CL1) are known to modulate inflammatory and fibroproliferative diseases. Here we investigate the role of CX3CR1/fractalkine in HCV-induced liver fibrosis.

METHODS

A genotype analysis of CX3CR1 variants was performed in 211 HCV-infected patients. Hepatic expression of CX3CR1 was studied in HCV-infected livers and isolated liver cell populations by RT-PCR and immunohistochemistry. The effects of fractalkine on mRNA expression of profibrogenic genes were determined in isolated hepatic stellate cells (HSC) and CX3CR1 genotypes were related to intrahepatic TIMP-1 mRNA levels.

RESULTS

The intrahepatic mRNA expression of CX3CR1 correlates with the stage of HCV-induced liver fibrosis (P=0.03). The CX3CR1 coding variant V249I is associated with advanced liver fibrosis, independent of the T280M variant (P=0.009). CX3CR1 is present on primary HSC and fractalkine leads to a suppression of tissue inhibitor of metalloproteinase (TIMP)-1 mRNA in HSC (P=0.03). Furthermore, CX3CR1 genotypes are associated with TIMP-1 mRNA expression in HCV-infected liver (P=0.03).

CONCLUSIONS

The results identify the fractalkine receptor CX3CR1 as susceptibility a gene for hepatic fibrosis in HCV infection. The modulation of TIMP-1 expression by fractalkine and CX3CR1 genotypes provides functional support for the observed genotype-phenotype association.

摘要

背景/目的:已知趋化因子受体CX3CR1及其特异性配体fractalkine(CX3CL1)可调节炎症和纤维增殖性疾病。在此,我们研究CX3CR1/fractalkine在丙型肝炎病毒(HCV)诱导的肝纤维化中的作用。

方法

对211例HCV感染患者进行CX3CR1变异体的基因型分析。通过逆转录聚合酶链反应(RT-PCR)和免疫组织化学研究HCV感染肝脏及分离的肝细胞群体中CX3CR1的肝内表达。在分离的肝星状细胞(HSC)中测定fractalkine对促纤维化基因mRNA表达的影响,并将CX3CR1基因型与肝内金属蛋白酶组织抑制剂1(TIMP-1)mRNA水平相关联。

结果

CX3CR1的肝内mRNA表达与HCV诱导的肝纤维化阶段相关(P = 0.03)。CX3CR1编码变异体V249I与晚期肝纤维化相关,独立于T280M变异体(P = 0.009)。CX3CR1存在于原代HSC上,fractalkine可导致HSC中金属蛋白酶组织抑制剂(TIMP)-1 mRNA的表达受到抑制(P = 0.03)。此外,CX3CR1基因型与HCV感染肝脏中TIMP-1 mRNA表达相关(P = 0.03)。

结论

结果确定趋化因子受体CX3CR1是HCV感染中肝纤维化的一个易感基因。fractalkine和CX3CR1基因型对TIMP-1表达的调节为观察到的基因型-表型关联提供了功能支持。

相似文献

1
The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection.趋化因子受体CX3CR1与丙型肝炎病毒慢性感染所致的肝纤维化有关。
J Hepatol. 2008 Feb;48(2):208-15. doi: 10.1016/j.jhep.2007.09.008. Epub 2007 Nov 20.
2
Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.趋化因子fractalkine在克罗恩病中的表达增加以及趋化因子受体T280M多态性与纤维狭窄性疾病表型的关联。
Am J Gastroenterol. 2006 Jan;101(1):99-106. doi: 10.1111/j.1572-0241.2005.00361.x.
3
Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma.功能性CX3CR1基因多态性V249I与肝细胞癌之间无关联。
Oncol Rep. 2005 May;13(5):957-63.
4
Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.fractalkine和CX3CR1参与肝内胆管上皮内淋巴细胞的募集。
Hepatology. 2005 Mar;41(3):506-16. doi: 10.1002/hep.20582.
5
The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.CX3CR1基因的V249I多态性与克罗恩病患者的纤维狭窄性疾病行为相关。
Eur J Gastroenterol Hepatol. 2008 Aug;20(8):748-55. doi: 10.1097/MEG.0b013e3282f824c9.
6
Expression of fractalkine (CX3CL1) and its receptor in endotoxin-induced uveitis.CX3CL1 及其受体在内毒素性葡萄膜炎中的表达。
Ophthalmic Res. 2009;42(3):160-6. doi: 10.1159/000230878. Epub 2009 Jul 31.
7
Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in periodontal diseased tissue.趋化因子(CX3CL1)及其受体CX3CR1在牙周病组织中的表达。
Clin Exp Immunol. 2005 Mar;139(3):506-12. doi: 10.1111/j.1365-2249.2005.02675.x.
8
Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.评估补体因子5变异体作为慢性丙型肝炎感染中晚期纤维化发展的遗传风险因素。
J Hepatol. 2008 Sep;49(3):339-45. doi: 10.1016/j.jhep.2008.05.021. Epub 2008 Jun 23.
9
Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension.趋化因子受体CX3CR1的多态性与系统性硬化症相关的肺动脉高压
Clin Dev Immunol. 2005 Dec;12(4):275-9. doi: 10.1080/17402520500303297.
10
Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.慢性丙型肝炎肝内CC趋化因子mRNA的半定量分析
Mediators Inflamm. 2004 Dec;13(5-6):357-9. doi: 10.1080/09629350400003159.

引用本文的文献

1
Prognostic assessment of early-stage liver cirrhosis induced by HCV using an integrated model of CX3CR1-associated immune infiltration genes.使用CX3CR1相关免疫浸润基因的综合模型对丙型肝炎病毒诱导的早期肝硬化进行预后评估。
Sci Rep. 2025 Jan 13;15(1):1771. doi: 10.1038/s41598-024-80422-1.
2
The Role of Macrophages in Hepatocellular Carcinoma and Their Therapeutic Potential.巨噬细胞在肝细胞癌中的作用及其治疗潜力。
Int J Mol Sci. 2024 Dec 7;25(23):13167. doi: 10.3390/ijms252313167.
3
An overview of the role of chemokine CX3CL1 (Fractalkine) and CX3C chemokine receptor 1 in systemic sclerosis.
趋化因子 CX3CL1( fractalkine)和 CX3C 趋化因子受体 1 在系统性硬化症中的作用概述。
Immun Inflamm Dis. 2024 Oct;12(10):e70034. doi: 10.1002/iid3.70034.
4
CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis.CX3CL1(趋化因子 Fractalkine)-CX3CR1 轴在炎症诱导的血管生成和肿瘤发生中的作用。
Int J Mol Sci. 2024 Apr 25;25(9):4679. doi: 10.3390/ijms25094679.
5
A common variant that alters SUN1 degradation associates with hepatic steatosis and metabolic traits in multiple cohorts.一种常见的变体改变了 SUN1 的降解,与多个队列中的肝脂肪变性和代谢特征有关。
J Hepatol. 2023 Nov;79(5):1226-1235. doi: 10.1016/j.jhep.2023.07.036. Epub 2023 Aug 9.
6
An Update on the Chemokine System in the Development of NAFLD.脂肪性肝病发病机制中趋化因子系统的最新研究进展。
Medicina (Kaunas). 2022 Jun 5;58(6):761. doi: 10.3390/medicina58060761.
7
Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.靶向固有免疫应答治疗丙型肝炎病毒相关肝纤维化的策略。
Drugs. 2021 Mar;81(4):419-443. doi: 10.1007/s40265-020-01458-x.
8
Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases.趋化因子在风湿性疾病治疗中的新作用
Immunotargets Ther. 2020 Nov 4;9:241-253. doi: 10.2147/ITT.S277991. eCollection 2020.
9
Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis.阐明新兴生物标志物早期预测肝纤维化的潜在抗纤维化机制。
Int J Mol Sci. 2020 Jul 3;21(13):4737. doi: 10.3390/ijms21134737.
10
Tenophages: a novel macrophage-like tendon cell population expressing CX3CL1 and CX3CR1.腱细胞:一种新型的巨噬细胞样腱细胞群体,表达 CX3CL1 和 CX3CR1。
Dis Model Mech. 2019 Dec 16;12(12):dmm041384. doi: 10.1242/dmm.041384.